
Tafluprost
Tafluprost is a prostaglandin Falpha that is prostaglandin F2alpha in which the carboxylic acid function has been converted to the corresponding isopropyl ester and the 3-hydroxy-1-octenyl side-chain is substituted by 3,3-difluoro-4-phenoxybut-1-enyl. Used for treatment of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It has a role as a prostaglandin receptor agonist. It is an isopropyl ester, a prostaglandins Falpha and an organofluorine compound. It is functionally related to a prostaglandin F2alpha. — ChEBI
- IUPAC name
- propan-2-yl (Z)-7-[(1R,2R,3R,5S)-2-[(E)-3,3-difluoro-4-phenoxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate
- Molecular formula
- C25H34F2O5
- Molecular weight
- 452.5 g/mol
- Exact mass
- 452.23743050 Da
- XLogP3
- 4.5
- Topological polar surface area
- 76.0 Ų
- Hydrogen-bond donors
- 2
- Hydrogen-bond acceptors
- 7
- Covalent units
- 1
- Defined stereocentres
- 4
Also known as
16 more reported names
External database identifiers
- ChEBI:CHEBI:66899
- ChEMBL:CHEMBL1963683
- EPA DTXSID:DTXSID401021504
- PubMed:21916788
- PubMed:21858491
- PubMed:19477946
- PubMed:15037111
Retrieved from NIH PubChem on 2026-09-02 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.